Zobrazeno 1 - 10
of 23
pro vyhledávání: '"L T, Friedhoff"'
Publikováno v:
Current Medical Research and Opinion. 20:13-18
to compare the efficacy and safety of 20 mg of lovastatin when administered once daily as an extended-release (ER) tablet or as an immediate-release (IR) tablet.Male or female patients aged 21-70 years with hypercholesterolemia who provided written i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d24a35ab09faf2cb886f3fc781deaf1
https://doi.org/10.1185/030079903125002612
https://doi.org/10.1185/030079903125002612
Autor:
S. L. Rogers, Hans-Jürgen Möller, Martin N. Rossor, L. T. Friedhoff, Alistair Burns, Serge Gauthier, H. Petit, Jane Hecker
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 10:237-244
Donepezil has been shown to be well tolerated and to improve cognition and global function in patients with mild to moderately severe Alzheimer’s disease (AD). The current trial was undertaken to investigate further the efficacy and safety of donep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba062688ad9cb463592bb38a8771a772
https://doi.org/10.1159/000017126
https://doi.org/10.1159/000017126
Autor:
A, Burns, M, Rossor, J, Hecker, S, Gauthier, H, Petit, H J, Möller, S L, Rogers, L T, Friedhoff
Publikováno v:
Dementia and geriatric cognitive disorders. 10(3)
Donepezil has been shown to be well tolerated and to improve cognition and global function in patients with mild to moderately severe Alzheimer's disease (AD). The current trial was undertaken to investigate further the efficacy and safety of donepez
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::488d8c4c3fa00fe06d7388d51e5dad29
https://pubmed.ncbi.nlm.nih.gov/10325453
https://pubmed.ncbi.nlm.nih.gov/10325453
Publikováno v:
Neurology. 52(1)
To the Editor: From their study of donepezil, Rogers et al. conclude that this drug is “efficacious in treating symptoms of memory and cognitive loss in patients with mild to moderately severe AD.”1 The following characteristics of their methodol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa2788355cda15cb628041f0c6e17d4f
https://pubmed.ncbi.nlm.nih.gov/9443470
https://pubmed.ncbi.nlm.nih.gov/9443470
Publikováno v:
British journal of clinical pharmacology. 46
The aim of this study was to characterize the pharmacokinetics and pharmacodynamics of donepezil HCl, a new, chemically distinct and specific acetylcholinesterase (AChE) inhibitor for the treatment of Alzheimer's disease, following multiple-dose admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a60bcf51d7aec0233aa47933e250e185
https://pubmed.ncbi.nlm.nih.gov/9839759
https://pubmed.ncbi.nlm.nih.gov/9839759
Autor:
S L, Rogers, L T, Friedhoff
Publikováno v:
British journal of clinical pharmacology. 46
The aim of this study was to characterize the pharmacokinetic and pharmacodynamic profile of donepezil HCl, a chemically distinct and specific acetylcholinesterase (AChE) inhibitor for the treatment of Alzheimer's disease, following administration of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d756a2c8251a0e723edae4f967b07362
https://pubmed.ncbi.nlm.nih.gov/9839758
https://pubmed.ncbi.nlm.nih.gov/9839758
Publikováno v:
British journal of clinical pharmacology. 46
The aim of this study was to evaluate the pharmacokinetics of donepezil HCl (5 mg) in patients with moderately to severely impaired renal function (creatinine clearance:30 ml min(-1) 1.73 m(-2)), following the administration of single oral doses.This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f9aec0ef803db1ae8ff6ebd3e55d298
https://pubmed.ncbi.nlm.nih.gov/9839768
https://pubmed.ncbi.nlm.nih.gov/9839768
Publikováno v:
British journal of clinical pharmacology. 46
The aim of this study was to examine the pharmacokinetics of donepezil HCl and ketoconazole separately, and in combination, following administration of single and multiple oral doses.This was an open-label, randomized, three-period crossover study in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::10d0897b66851cece6f367e5e4290939
https://pubmed.ncbi.nlm.nih.gov/9839763
https://pubmed.ncbi.nlm.nih.gov/9839763
Publikováno v:
British journal of clinical pharmacology. 46
The aim of this study was to evaluate the pharmacokinetic profile of donepezil HCl (5 mg) in patients with impaired hepatic function, following the administration of single oral doses.This was an open-label, non-randomized study comparing the pharmac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ea9366219c4bce16442d9ff4ce91c8b
https://pubmed.ncbi.nlm.nih.gov/9839767
https://pubmed.ncbi.nlm.nih.gov/9839767
Publikováno v:
British journal of clinical pharmacology. 46
The aim of the study was to examine the pharmacokinetic and pharmacodynamic profiles of single doses of warfarin (25 mg) following administration alone, and in combination with multiple doses of donepezil HCl (10 mg day(-1)) in healthy volunteers.Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40d41e52db5074d3c74e2b9d9646a43a
https://pubmed.ncbi.nlm.nih.gov/9839766
https://pubmed.ncbi.nlm.nih.gov/9839766